Deep vein thrombosis · prevention of venous thromboembolism in patients with lower‐limb immobilization
Low molecular weight heparin probably leads to lower deep venous thrombosis compared with no prophylaxis or placebo (moderate certainty).
1 finding from 1 review
Pulmonary embolism · prevention of venous thromboembolism in patients with lower‐limb immobilization
Low molecular weight heparin showed no clear difference in pulmonary embolism compared with no prophylaxis or placebo (low certainty).
1 finding from 1 review
Symptomatic venous thromboembolism · prevention of venous thromboembolism in patients with lower‐limb immobilization
Low molecular weight heparin may leads to lower symptomatic venous thromboembolism compared with no prophylaxis or placebo (low certainty).
1 finding from 1 review
Mortality due to pulmonary embolism · prevention of venous thromboembolism in patients with lower‐limb immobilization
1 finding from 1 review
Mortality due to other causes · prevention of venous thromboembolism in patients with lower‐limb immobilization
Low molecular weight heparin showed no clear difference in mortality due to other causes compared with no prophylaxis or placebo (low certainty).
1 finding from 1 review
Adverse outcomes · prevention of venous thromboembolism in patients with lower‐limb immobilization
Low molecular weight heparin showed no clear difference in adverse outcomes compared with no prophylaxis or placebo (low certainty).
1 finding from 1 review
Adherence to antipsychotic medication: number of missed doses, average endpoint data, short term (up to 6 months) · People receiving lipid‐lowering medications
Summary of findings table for the comparison of 'intensified patient… probably leads to higher medication adherence at ≤ 6 months compared with 'usual care' (moderate certainty).
1 finding from 1 review
Medication adherence (dichotomous) · People receiving lipid‐lowering medications
Summary of findings table for the comparison of 'intensified patient… leads to higher medication adherence at > 6 months compared with 'usual care' (high certainty).
1 finding from 1 review
LDL‐C reduction (LDL‐C) · People receiving lipid‐lowering medications
1 finding from 1 review
Reduction in total serum cholesterol at ≤ 6 months (mg/dL) · People receiving lipid‐lowering medications
1 finding from 1 review
Reduction in total serum cholesterol at > 6 mos (mg/dL) · People receiving lipid‐lowering medications
1 finding from 1 review
Intervention not reported
Incidence of any surgical site infection · lower limb arterial surgery
It is very uncertain whether the intervention changes incidence of any surgical site infection (very low certainty).
1 finding from 1 review
Intervention not reported
Incidence of wound dehiscence · lower limb arterial surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Incidence of reoperation for wound or graft‐related complications · lower limb arterial surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Changes in health‐related quality of life · lower limb arterial surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Amputation · people with peripheral arterial disease of the lower limbs
Drug‐eluting balloon showed no clear difference in amputation compared with uncoated balloon angioplasty at 12 months (high certainty).
1 finding from 1 review
Primary vessel patency · people with peripheral arterial disease of the lower limbs
Drug‐eluting balloon leads to higher primary vessel patency compared with uncoated balloon angioplasty at 12 months (high certainty).
1 finding from 1 review
Target lesion revascularization · people with peripheral arterial disease of the lower limbs
Drug‐eluting balloon may leads to lower target lesion revascularization compared with uncoated balloon angioplasty at 12 months (low certainty).
1 finding from 1 review
Binary restenosis · people with peripheral arterial disease of the lower limbs
Drug‐eluting balloon probably leads to lower binary restenosis compared with uncoated balloon angioplasty at 12 months (moderate certainty).
1 finding from 1 review
Death · people with peripheral arterial disease of the lower limbs
Drug‐eluting balloon showed no clear difference in death compared with uncoated balloon angioplasty at 12 months (high certainty).
1 finding from 1 review